FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
- 26 January 2015
- journal article
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 17 (3) , 306-317
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder in which neuroinflammation plays an important role. FLZ is a novel synthetic derivative of natural squamosamide. Previous studies demonstrated that FLZ had neuroprotective effects on AD models and showed strong anti-inflammatory property in Parkinson's disease models. However, whether the neuroprotective effects of FLZ on AD are associated with its anti-inflammatory property is still not fully elucidated. In this study, we aimed to investigate the ability of FLZ in modulating inflammation. The results showed that FLZ significantly improved memory deficits and alleviated neuronal damage as well as neuronal loss in the hippocampus of mice intracerebroventricular injected with lipopolysaccharide (LPS). Mechanistic studies revealed that the neuroprotective effects of FLZ were due to the suppression of neuroinflammation induced by LPS, as indicated by inactivation of astrocytes and microglia, reduced production of tumor necrosis factor-α, interleukin-1β, and nitric oxide, as well as decreased expression of cyclooxygenase-2 and inducible nitric oxide synthase. The beneficial effects of FLZ on AD were further supported by the finding that FLZ attenuated β-amyloid production through inhibiting β-amyloid precursor protein cleaving enzyme 1 expression. These results suggested that anti-inflammatory agent could be useful for the treatment of AD.Keywords
This publication has 18 references indexed in Scilit:
- Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP/PS1 transgenic miceNeurobiology of Disease, 2014
- Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imagingJournal of Neuroinflammation, 2014
- The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s DiseaseNeuron, 2014
- Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memoryFrontiers in Neuroscience, 2014
- Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease modelsNeuropharmacology, 2013
- Refractive Errors in 3–6 Year-Old Chinese Children: A Very Low Prevalence of Myopia?PLOS ONE, 2013
- Inhibitory role of the spinal cholinergic system in the control of urethral continence reflex during sneezing in ratsNeurourology and Urodynamics, 2013
- Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activityJournal of Neuroinflammation, 2008
- Protective effects of compound FLZ on beta-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment1Acta Pharmacologica Sinica, 2006